出版：MarketsandMarkets（マーケッツアンドマーケッツ） 出版年月：2023年10月
Biopsy Devices Market – Global Forecast to 2028
生検装置市場 : 製品 (針生検、吸引細胞診、吸引補助生検)、用途 (乳房生検、肺生検、前立腺生検)、ガイダンス (定位手術、超音波)、エンドユーザー (病院) 、地域別 – 2028年までの世界予測
Biopsy Devices Market by Product (Core Needle Biopsy, Aspiration Biopsy, Vacuum Assisted Biopsy), Application (Breast Biopsy, Lung Biopsy, Prostate Biopsy), Guidance (Stereotactic, Ultrasound), End User (Hospital) & Region – Global Forecast to 2028
| ページ数 | 229 |
| 図表数 | 209 |
| 種別 | 英文調査報告書 |
| 価格 |
Report Overview
The global biopsy devices market is projected to reach USD 12.6 billion by 2028 from USD 6.6 billion in 2023, at a CAGR of 14.0% from 2023 to 2028. Factors such as the the rising incidence of cancer and other chronic diseases has spurred the need for more frequent and accurate tissue sampling. Moreover, increased awareness of the importance of early disease detection and personalized medicine has driven demand for advanced biopsy devices.
“The Needle based biopsy instruments segment of product segment l held the largest share of the market in 2022”
Based on product, the biopsy devices market is segmented into needle based biopsy instruments, localization wire, biopsy forceps, procedure tray, biopsy table and other products. The needle based biopsy instruments segment held a major share of the market. advancements in needle biopsy technologies, such as improved guidance systems and the development of more specialized needles for different tissue types, have increased the accuracy and reliability of these procedures, further driving their adoption.
“The breast biopsy segment is projected to register the highest CAGR during the forecast period”
Based on application, the biopsy devices market is segmented into breast, lung, kidney, colorectal, bone marrow, prostate and other applications. The breast biopsy segment accounted for the largest market share in 2022. breast cancer remains one of the most prevalent cancers globally, emphasizing the critical role of early and accurate diagnosis. As breast cancer awareness and screening programs expand, the demand for biopsy procedures to confirm diagnoses and determine treatment strategies is on the rise.
“The diagnostic imaging centers segment for end user segment is projected to register a significant CAGR during the forecast period”
On the basis of end user, the biopsy devices market is segmented into hospitals and breast care centers, diagnostic imaging cneters, academic and research institutes. The diagnostic imaging centers segment accounted for the significant share of the biopsy devices market in 2022. By advanced biopsy deives diagnostic imaging centers can provide more accurate and reliable diagnoses, leading to better treatment planning and improved patient outcomes. Moreover, the versatility of biopsy devices imaging enables these centers to cater to a wide range of medical specialties, effectively serving patients with diverse healthcare needs.
“The market in the North America region is expected to witness the highest growth during the forecast period.”
The biopsy devices market in the North America region is expected to register a CAGR during the forecast period, primarily due to the high healthcare spending in the region, rising prevalence of target diseases, increasing research activities, growing number of cosmetic surgeries, and technological advancements in imaging systems.
A breakdown of the primary participants referred to for this report is provided below:
• By Company Type: Tier 1–48%, Tier 2–36%, and Tier 3– 16%
• By Designation: Director-level–14%, C-level–10%, and Others–76%
• By Region: North America–40%, Europe–32%, Asia Pacific–20%, Latin America–5%, and the Middle East & Africa–3%
The prominent players in the biopsy devices market are Becton, Dickinson and Company (US), Cook Group Incorporated (US), Devicor Medical Products, Inc., (Leica Biosystems) (US), Hologic, Inc. (US), Argon Medical Devices (US), B. Braun SE (Germany), Cardinal Health, Inc. (US), Olympus Corporation (Japan), Boston Scientific Corporation (US), FUJIFILM Holdings Corporation (Japan), INRAD, Inc. (US), and Medtronic plc (Ireland) among others.
Research Coverage
This report studies the biopsy devices market based on technology, display, portability, component, application, enduser, and region. It also covers the factors affecting market growth, analyzes the various opportunities and challenges in the market, and provides details of the competitive landscape for market leaders. Furthermore, the report analyzes micro markets with respect to their growth trends and forecasts the revenue of the market segments with respect to five main regions (and the respective countries in these regions).
Reasons to Buy the Report
The report will help the market leaders/new entrants with information on the closest approximations of the revenue numbers for the overall biopsy devices market and the subsegments. This report will help stakeholders understand the competitive landscape and gain more insights to position their businesses better and plan suitable go-to-market strategies. The report also helps stakeholders understand the market pulse and provides information on key market drivers, restraints, challenges, and opportunities.
This report provides insights on the following pointers:
• Analysis of key drivers (rising target patient population, growing adoption of biopsy devices imaging devices, technological advancement, and increasing investment, funds, and grants by public-private organizations), restraints (high capital and operational cost, unfavorable regulatory guidelines), opportunities (improving healthcare infrastructure across emerging countries, biopsy devices utilization for breast imaging, promising product pipeline), and challenges (availability of alternate imaging technologies) influencing the growth of the biopsy devices market
• Product Development/Innovation: Detailed insights on upcoming technologies, research & development activities, and new product & service launches in the biopsy devices market
• Market Development: Comprehensive information about lucrative markets–the report analyses the biopsy devices market across varied regions.
• Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the biopsy devices market
• Competitive Assessment: In-depth assessment of market shares, growth strategies, and service offerings of leading players like Becton, Dickinson and Company (US), Cook Group Incorporated (US), Devicor Medical Products, Inc., (Leica Biosystems) (US), Hologic, Inc. (US), Argon Medical Devices (US), B. Braun SE (Germany), Cardinal Health, Inc. (US), Olympus Corporation (Japan), and Boston Scientific Corporation (US) among others.
Table of Contents
1 INTRODUCTION 28
1.1 STUDY OBJECTIVES 28
1.2 MARKET DEFINITION 28
1.2.1 INCLUSIONS AND EXCLUSIONS 29
1.2.2 MARKET SEGMENTATION 29
1.2.3 YEARS CONSIDERED 30
1.2.4 CURRENCY CONSIDERED 30
1.3 STAKEHOLDERS 30
1.4 SUMMARY OF CHANGES 31
1.5 RECESSION IMPACT 31
2 RESEARCH METHODOLOGY 32
2.1 RESEARCH DATA 32
FIGURE 1 RESEARCH DESIGN 32
2.1.1 SECONDARY RESEARCH 33
2.1.2 PRIMARY RESEARCH 34
2.1.2.1 Primary sources 34
2.1.2.2 Key industry insights 35
2.1.2.3 Breakdown of primaries 35
FIGURE 2 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY AND DEMAND-SIDE PARTICIPANTS 35
FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION 36
2.2 MARKET SIZE ESTIMATION METHODOLOGY 36
FIGURE 4 RESEARCH METHODOLOGY: HYPOTHESIS BUILDING 37
2.2.1 BOTTOM-UP APPROACH 37
2.2.1.1 Approach 1: Company revenue estimation approach 37
FIGURE 5 MARKET SIZE ESTIMATION FOR NEEDLE-BASED BIOPSY DEVICES AND ACCESSORY MARKET 38
FIGURE 6 MARKET SIZE ESTIMATION FOR LIQUID BIOPSY APPROACH 1 (COMPANY REVENUE ESTIMATION) 38
FIGURE 7 REVENUE SHARE ANALYSIS: ILLUSTRATIVE EXAMPLE OF BECTON, DICKINSON, AND COMPANY 39
2.2.1.2 Approach 2: Customer-based market estimation 39
2.2.1.3 Top-down approach of biopsy devices market 40
2.2.1.4 Approach 3: CAGR projections 40
FIGURE 8 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS 40
2.2.2 END USER-BASED MARKET SIZE ESTIMATION 41
FIGURE 9 BIOPSY DEVICES MARKET: END USER-BASED ESTIMATION 41
2.3 MARKET BREAKDOWN AND DATA TRIANGULATION 42
FIGURE 10 DATA TRIANGULATION METHODOLOGY 42
2.3.1 MARKET SHARE ASSESSMENT 43
2.4 RESEARCH ASSUMPTIONS 43
2.5 GROWTH RATE ASSUMPTIONS 43
2.6 RESEARCH LIMITATIONS 44
2.6.1 SCOPE-RELATED LIMITATIONS 44
2.6.2 METHODOLOGY-RELATED LIMITATIONS 44
2.7 RISK ASSESSMENT 44
2.7.1 RISK ASSESSMENT ANALYSIS 44
2.8 RECESSION IMPACT ANALYSIS 45
3 EXECUTIVE SUMMARY 46
FIGURE 11 BIOPSY DEVICES MARKET, BY PRODUCT, 2023 VS. 2028 (USD MILLION) 46
FIGURE 12 BIOPSY DEVICES MARKET, BY APPLICATION, 2023 VS. 2028 (USD MILLION) 47
FIGURE 13 BIOPSY DEVICES MARKET, BY END USER, 2023 VS. 2028 (USD MILLION) 47
FIGURE 14 GEOGRAPHICAL SNAPSHOT: BIOPSY DEVICES MARKET 48
4 PREMIUM INSIGHTS 49
4.1 BIOPSY DEVICES MARKET OVERVIEW 49
FIGURE 15 GROWING DEMAND FOR MINIMALLY INVASIVE SURGERY TO DRIVE MARKET 49
4.2 NORTH AMERICA: BIOPSY DEVICES MARKET, BY PRODUCT, 2023 VS. 2028 (USD MILLION) 50
FIGURE 16 LIQUID BIOPSY INSTRUMENTS TO DOMINATE NORTH AMERICAN MARKET IN 2023 50
4.3 ASIA PACIFIC: BIOPSY DEVICES MARKET, BY END USER, 2023 VS. 2028 (USD MILLION) 50
FIGURE 17 HOSPITALS & BREAST CARE CENTERS TO DOMINATE ASIA PACIFIC MARKET IN 2023 50
4.4 EUROPE: BIOPSY DEVICES MARKET, BY GUIDANCE TECHNIQUE, 2023 VS. 2028 (USD MILLION) 51
FIGURE 18 NON-IMAGE-GUIDED BIOPSY SEGMENT TO DOMINATE EUROPEAN MARKET DURING FORECAST PERIOD 51
4.5 BIOPSY DEVICES MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES 51
FIGURE 19 US TO WITNESS HIGHEST GROWTH DURING FORECAST PERIOD 51
5 MARKET OVERVIEW 52
5.1 INTRODUCTION 52
5.2 MARKET DYNAMICS 53
FIGURE 20 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES: BIOPSY DEVICES MARKET 53
5.2.1 DRIVERS 53
5.2.1.1 Rising prevalence of cancer 53
5.2.1.2 Increasing preference for minimally invasive surgeries 54
5.2.1.3 Initiatives undertaken by governments and global health organizations 54
5.2.1.4 Increased number of hospitals and diagnostic centers 55
5.2.1.5 Improved reimbursement scenario 55
5.2.2 RESTRAINTS 55
5.2.2.1 Increasing product recalls 55
TABLE 1 INDICATIVE LIST OF FDA PRODUCT RECALLS FOR BIOPSY DEVICES (2020–2021) 56
5.2.2.2 High risk of infections for patients 56
5.2.3 OPPORTUNITIES 56
5.2.3.1 Technological innovations in biopsy devices 56
5.2.3.2 Growing investments in emerging economies 57
5.2.4 CHALLENGES 57
5.2.4.1 Underdeveloped healthcare infrastructure in emerging economies 57
5.3 PORTER’S FIVE FORCES ANALYSIS 58
TABLE 2 PORTER’S FIVE FORCES ANALYSIS: BIOPSY DEVICES MARKET 58
5.3.1 THREAT OF NEW ENTRANTS 58
5.3.2 THREAT OF SUBSTITUTES 58
5.3.3 BARGAINING POWER OF SUPPLIERS 59
5.3.4 BARGAINING POWER OF BUYERS 59
5.3.5 INTENSITY OF COMPETITIVE RIVALRY 59
5.4 REGULATORY ANALYSIS 59
5.4.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 59
5.4.1.1 North America 59
5.4.1.1.1 US 59
TABLE 3 BIOPSY DEVICES UNDER 21 CFR 876.1075 WITH PRODUCT CODES 60
5.4.1.2 Europe 61
FIGURE 21 EUROPE: CE MARK APPROVAL PROCESS FOR BIOPSY DEVICES 61
5.4.1.3 Asia Pacific 61
5.4.1.3.1 Japan 61
TABLE 4 JAPAN: CLASSIFICATION OF MEDICAL DEVICES AND REVIEWING BODIES 61
TABLE 5 NOMENCLATURE OF APPLICABLE MEDICAL DEVICES WITH CODES 62
5.4.1.3.2 China 62
5.4.1.3.3 India 63
TABLE 6 INDIA: REGULATORY CLASSIFICATION FOR MEDICAL DEVICES 63
5.4.1.4 Latin America 63
5.4.1.4.1 Brazil 63
FIGURE 22 BRAZIL: REGULATORY PROCESS FOR MEDICAL DEVICES 64
TABLE 7 BRAZIL: TIME, COST, AND COMPLEXITY OF REGISTRATION PROCESS 64
5.4.1.4.2 Mexico 65
FIGURE 23 MEXICO: REGULATORY PROCESS FOR MEDICAL DEVICES 65
TABLE 8 MEXICO: TIME, COST, AND COMPLEXITY OF REGISTRATION PROCESS 66
5.4.2 REGULATORY TRENDS FOR BIOPSY DEVICES MARKET 66
5.5 REIMBURSEMENT SCENARIO ANALYSIS 67
TABLE 9 MEDICAL REIMBURSEMENT CPT CODES FOR BIOPSY DEVICE PROCEDURES IN US (2021) 68
5.6 ECOSYSTEM/MARKET MAP 69
5.7 VALUE CHAIN ANALYSIS 69
5.7.1 RESEARCH & PRODUCT DEVELOPMENT 69
5.7.2 RAW MATERIAL PROCUREMENT AND MANUFACTURING 69
5.7.3 SHIPMENT, MARKETING & SALES, AND POST-SALES SERVICES 69
FIGURE 24 VALUE CHAIN ANALYSIS—MAXIMUM VALUE ADDED DURING MANUFACTURING PHASE 70
5.8 SUPPLY CHAIN ANALYSIS 70
5.8.1 PROMINENT COMPANIES 70
5.8.2 SMALL AND MEDIUM-SIZED ENTERPRISES 70
5.8.3 END USERS 70
TABLE 10 ROLE IN ECOSYSTEM: BIOPSY DEVICES MARKET 71
FIGURE 25 SUPPLY CHAIN ANALYSIS: BIOPSY DEVICES MARKET 72
5.9 PATENT ANALYSIS 72
FIGURE 26 PATENT DETAILS FOR NEEDLE-BASED BIOPSY INSTRUMENTS (JANUARY 2013–AUGUST 2023) 72
FIGURE 27 PATENTS FOR BIOPSY LOCALIZATION WIRES (JANUARY 2013–AUGUST 2023) 73
FIGURE 28 PATENTS FOR BIOPSY FORCEPS (JANUARY 2013–AUGUST 2023) 74
5.10 TRADE ANALYSIS 74
TABLE 11 IMPORT DATA FOR BIOPSY DEVICES (HS CODE 901839), BY COUNTRY, 2018–2022 (USD) 74
TABLE 12 EXPORT DATA FOR BIOPSY DEVICES (HS CODE 901839), BY COUNTRY, 2018–2022 (USD) 75
5.11 KEY STAKEHOLDERS & BUYING CRITERIA 75
5.11.1 KEY STAKEHOLDERS IN BIOPSY DEVICES MARKET 75
FIGURE 29 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS OF BIOPSY DEVICES 75
TABLE 13 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS OF BIOPSY DEVICES 76
5.11.2 BUYING CRITERIA FOR BIOPSY DEVICES 76
FIGURE 30 KEY BUYING CRITERIA FOR BIOPSY DEVICES 76
TABLE 14 KEY BUYING CRITERIA FOR BIOPSY DEVICES 76
5.12 KEY CONFERENCES & EVENTS (2023–2025) 77
TABLE 15 LIST OF KEY CONFERENCES & EVENTS, 2023–2025 77
5.13 TECHNOLOGY ANALYSIS 77
5.14 CASE STUDY ANALYSIS 78
TABLE 16 CASE STUDY 1: MAINTAINING STRONG FOCUS ON TECHNOLOGICAL INNOVATION AND ADDRESSING REGULATORY COMPLIANCE 78
TABLE 17 CASE STUDY 2: PROVIDING COMPREHENSIVE TRAINING PROGRAMS FOR EVOLVING BIOPSY TECHNIQUES 79
5.15 PRICING ANALYSIS 79
TABLE 18 REGION-WISE PRICE RANGE FOR BIOPSY DEVICES INSTRUMENTS, 2023 79
6 BIOPSY DEVICES MARKET, BY PRODUCT 80
6.1 INTRODUCTION 81
TABLE 19 BIOPSY DEVICES MARKET, BY PRODUCT TYPE, 2021–2028 (USD MILLION) 81
6.2 LIQUID BIOPSY INSTRUMENTS 81
6.2.1 ONGOING RESEARCH AND CLINICAL TRIALS TO DELIVER NOVEL SOLUTIONS IN MARKET 81
TABLE 20 LIQUID BIOPSY INSTRUMENTS MARKET, BY REGION, 2021–2028 (USD MILLION) 82
TABLE 21 LIQUID BIOPSY INSTRUMENTS MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 82
TABLE 22 LIQUID BIOPSY INSTRUMENTS MARKET, BY END USER, 2021–2028 (USD MILLION) 83
6.3 NEEDLE-BASED BIOPSY INSTRUMENTS 83
TABLE 23 NEEDLE-BASED BIOPSY INSTRUMENTS MARKET, BY TYPE, 2021–2028 (USD MILLION) 83
TABLE 24 NEEDLE-BASED BIOPSY INSTRUMENTS MARKET, BY REGION, 2021–2028 (USD MILLION) 84
TABLE 25 NEEDLE-BASED BIOPSY INSTRUMENTS MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 84
TABLE 26 NEEDLE-BASED BIOPSY INSTRUMENTS MARKET, BY END USER, 2021–2028 (USD MILLION) 85
6.3.1 CORE BIOPSY DEVICES 85
TABLE 27 CORE BIOPSY DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 86
TABLE 28 CORE BIOPSY DEVICES MARKET, BY REGION, 2021–2028 (USD MILLION) 86
6.3.1.1 Core biopsy needles 86
6.3.1.1.1 Greater diagnostic accuracy and improved imaging capabilities to boost demand 86
TABLE 29 CORE BIOPSY NEEDLES MARKET, BY REGION, 2021–2028 (USD MILLION) 87
6.3.1.2 Core biopsy guns 87
6.3.1.2.1 Rapidity, efficiency, and accuracy to support adoption 87
TABLE 30 CORE BIOPSY GUNS MARKET, BY REGION, 2021–2028 (USD MILLION) 88
6.3.2 ASPIRATION BIOPSY NEEDLES 88
6.3.2.1 Innovations in needle design, including thinner profiles and improved tip configurations, to drive market 88
TABLE 31 ASPIRATION BIOPSY NEEDLES MARKET, BY REGION, 2021–2028 (USD MILLION) 89
6.3.3 VACUUM-ASSISTED BIOPSY DEVICES 89
TABLE 32 VACUUM-ASSISTED BIOPSY DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 90
TABLE 33 VACUUM-ASSISTED BIOPSY DEVICES MARKET, BY REGION, 2021–2028 (USD MILLION) 90
6.3.3.1 Vacuum-assisted biopsy systems 90
6.3.3.1.1 Increasing demand for early and accurate cancer detection, particularly in breast cancer, to drive market 90
TABLE 34 VACUUM-ASSISTED BIOPSY SYSTEMS MARKET, BY REGION, 2021–2028 (USD MILLION) 91
6.3.3.2 Vacuum-assisted biopsy needles 91
6.3.3.2.1 Innovative design and ability to retrieve larger specimens to support adoption 91
TABLE 35 VACUUM-ASSISTED BIOPSY NEEDLES MARKET, BY REGION, 2021–2028 (USD MILLION) 92
6.4 PROCEDURE TRAYS 92
6.4.1 DEMAND FOR EARLY CANCER DETECTION AND MINIMALLY INVASIVE TECHNIQUES TO DRIVE MARKET 92
TABLE 36 PROCEDURE TRAYS MARKET, BY REGION, 2021–2028 (USD MILLION) 93
TABLE 37 PROCEDURE TRAYS MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 93
TABLE 38 PROCEDURE TRAYS MARKET, BY END USER, 2021–2028 (USD MILLION) 94
6.5 LOCALIZATION WIRES 94
6.5.1 ABILITY TO DETECT PRECISE TARGET LOCATIONS TO DRIVE MARKET 94
TABLE 39 LOCALIZATION WIRES MARKET, BY REGION, 2021–2028 (USD MILLION) 95
TABLE 40 LOCALIZATION WIRES MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 95
TABLE 41 LOCALIZATION WIRES MARKET, BY END USER, 2021–2028 (USD MILLION) 96
6.6 BIOPSY TABLES 96
6.6.1 EASE OF POSITIONING TO DRIVE DEMAND FOR BIOPSY TABLES 96
TABLE 42 BIOPSY TABLES MARKET, BY REGION, 2021–2028 (USD MILLION) 97
TABLE 43 BIOPSY TABLES MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 97
TABLE 44 BIOPSY TABLES MARKET, BY END USER, 2021–2028 (USD MILLION) 98
6.7 BIOPSY FORCEPS 98
TABLE 45 BIOPSY FORCEPS MARKET, BY TYPE, 2021–2028 (USD MILLION) 98
TABLE 46 BIOPSY FORCEPS MARKET, BY REGION, 2021–2028 (USD MILLION) 99
TABLE 47 BIOPSY FORCEPS MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 99
TABLE 48 BIOPSY FORCEPS MARKET, BY END USER, 2021–2028 (USD MILLION) 100
6.7.1 GENERAL BIOPSY FORCEPS 100
6.7.1.1 Demand for minimally invasive procedures and precise diagnostics continues to surge market growth 100
TABLE 49 GENERAL BIOPSY FORCEPS MARKET, BY REGION, 2021–2028 (USD MILLION) 100
6.7.2 HOT BIOPSY FORCEPS 101
6.7.2.1 Unique ability to cut and coagulate tissue simultaneously to support adoption 101
TABLE 50 HOT BIOPSY FORCEPS MARKET, BY REGION, 2021–2028 (USD MILLION) 101
6.8 OTHER PRODUCTS 101
TABLE 51 OTHER BIOPSY PRODUCTS MARKET, BY REGION, 2021–2028 (USD MILLION) 102
TABLE 52 OTHER BIOPSY PRODUCTS MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 102
TABLE 53 OTHER BIOPSY PRODUCTS MARKET, BY END USER, 2021–2028 (USD MILLION) 103
7 BIOPSY DEVICES MARKET, BY GUIDANCE TECHNIQUE 104
7.1 INTRODUCTION 105
TABLE 54 BIOPSY DEVICES MARKET, BY GUIDANCE TECHNIQUE, 2021–2028 (USD MILLION) 105
7.2 NON-IMAGE-GUIDED BIOPSY 105
7.2.1 WIDE USAGE IN SITUATIONS WHERE IMAGING TECHNOLOGY IS INACCESSIBLE TO DRIVE MARKET 105
TABLE 55 NON-IMAGE-GUIDED BIOPSY MARKET, BY REGION, 2021–2028 (USD MILLION) 106
7.3 IMAGE-GUIDED BIOPSY 106
TABLE 56 IMAGE-GUIDED BIOPSY MARKET, BY TYPE, 2021–2028 (USD MILLION) 106
TABLE 57 IMAGE-GUIDED BIOPSY MARKET, BY REGION, 2021–2028 (USD MILLION) 107
7.3.1 ULTRASOUND-GUIDED BIOPSY 107
7.3.1.1 Advantages of technique to boost usage 107
TABLE 58 ULTRASOUND-GUIDED BIOPSY MARKET, BY REGION, 2021–2028 (USD MILLION) 107
7.3.2 STEREOTACTIC-GUIDED BIOPSY 108
7.3.2.1 Efficiency and accuracy to support adoption 108
TABLE 59 STEREOTACTIC-GUIDED BIOPSY MARKET, BY REGION, 2021–2028 (USD MILLION) 108
7.3.3 MRI-GUIDED BIOPSY 108
7.3.3.1 High cost and low specificity to affect demand 108
TABLE 60 MRI-GUIDED BIOPSY MARKET, BY REGION, 2021–2028 (USD MILLION) 109
7.3.4 OTHER IMAGE-GUIDED BIOPSY TECHNIQUES 109
TABLE 61 OTHER IMAGE-GUIDED BIOPSY TECHNIQUES MARKET, BY REGION, 2021–2028 (USD MILLION) 109
8 BIOPSY DEVICES MARKET, BY APPLICATION 110
8.1 INTRODUCTION 111
TABLE 62 BIOPSY DEVICES MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 111
8.2 LUNG CANCER 111
8.2.1 LUNG CANCER TO HOLD LARGEST MARKET SHARE 111
TABLE 63 BIOPSY DEVICES MARKET FOR LUNG CANCER, BY REGION, 2021–2028 (USD MILLION) 112
8.3 BREAST CANCER 112
8.3.1 INCREASING DEMAND FOR EARLY AND ACCURATE DIAGNOSIS AND RISING PREVALENCE TO DRIVE MARKET 112
TABLE 64 BIOPSY DEVICES MARKET FOR BREAST CANCER, BY REGION, 2021–2028 (USD MILLION) 113
8.4 COLORECTAL CANCER 113
8.4.1 RISING EMPHASIS ON EARLY DETECTION AND SCREENING TO SUPPORT MARKET GROWTH 113
TABLE 65 BIOPSY DEVICES MARKET FOR COLORECTAL CANCER, BY REGION, 2021–2028 (USD MILLION) 114
8.5 KIDNEY CANCER 114
8.5.1 ADVANCEMENTS IN DIAGNOSTICS AND GROWING EMPHASIS ON CANCER THERAPEUTICS TO DRIVE MARKET 114
TABLE 66 BIOPSY DEVICES MARKET FOR KIDNEY CANCER, BY REGION, 2021–2028 (USD MILLION) 115
8.6 PROSTATE CANCER 115
8.6.1 RISING INCIDENCE OF PROSTATE CANCER AND GROWING AGING POPULATION TO SUPPORT DEMAND FOR BIOPSY DEVICES 115
TABLE 67 BIOPSY DEVICES MARKET FOR PROSTATE CANCER, BY REGION, 2021–2028 (USD MILLION) 116
8.7 BONE MARROW BIOPSY 116
8.7.1 RISING EMPHASIS ON BONE MARROW BIOPSIES TO SUPPORT MARKET GROWTH 116
TABLE 68 BIOPSY DEVICES MARKET FOR BONE MARROW BIOPSY, BY REGION, 2021–2028 (USD MILLION) 117
8.8 OTHER APPLICATIONS 117
TABLE 69 BIOPSY DEVICES MARKET FOR OTHER APPLICATIONS, BY REGION, 2021–2028 (USD MILLION) 117
9 BIOPSY DEVICES MARKET, BY END USER 118
9.1 INTRODUCTION 119
TABLE 70 BIOPSY DEVICES MARKET, BY END USER, 2021–2028 (USD MILLION) 119
9.2 HOSPITALS & BREAST CARE CENTERS 119
9.2.1 HIGH PROCEDURAL VOLUMES TO ENSURE SUSTAINED DEMAND FOR BIOPSY DEVICES 119
TABLE 71 BIOPSY DEVICES MARKET FOR HOSPITALS & BREAST CARE CENTERS, BY REGION, 2021–2028 (USD MILLION) 120
9.3 DIAGNOSTIC IMAGING CENTERS 120
9.3.1 INCREASING NUMBER OF PRIVATE IMAGING CENTERS TO SUPPORT MARKET GROWTH 120
TABLE 72 BIOPSY DEVICES MARKET FOR DIAGNOSTIC IMAGING CENTERS, BY REGION, 2021–2028 (USD MILLION) 121
9.4 ACADEMIC & RESEARCH INSTITUTES 121
9.4.1 GROWING AVAILABILITY OF RESEARCH GRANTS AND FUNDING TO DRIVE MARKET 121
TABLE 73 BIOPSY DEVICES MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2021–2028 (USD MILLION) 122
9.5 OTHER END USERS 122
TABLE 74 BIOPSY DEVICES MARKET FOR OTHER END USERS, BY REGION, 2021–2028 (USD MILLION) 123
10 BIOPSY DEVICES MARKET, BY REGION 124
10.1 INTRODUCTION 125
TABLE 75 BIOPSY DEVICES MARKET, BY REGION, 2021–2028 (USD MILLION) 125
10.2 NORTH AMERICA 125
10.2.1 RECESSION IMPACT 125
FIGURE 31 NORTH AMERICA: BIOPSY DEVICES MARKET SNAPSHOT 126
TABLE 76 NORTH AMERICA: BIOPSY DEVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 126
TABLE 77 NORTH AMERICA: BIOPSY DEVICES MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 127
TABLE 78 NORTH AMERICA: NEEDLE-BASED BIOPSY INSTRUMENTS MARKET, BY TYPE, 2021–2028 (USD MILLION) 127
TABLE 79 NORTH AMERICA: CORE BIOPSY DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 128
TABLE 80 NORTH AMERICA: VACUUM-ASSISTED BIOPSY DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 128
TABLE 81 NORTH AMERICA: BIOPSY FORCEPS MARKET, BY TYPE, 2021–2028 (USD MILLION) 128
TABLE 82 NORTH AMERICA: BIOPSY DEVICES MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 129
TABLE 83 NORTH AMERICA: BIOPSY DEVICES MARKET, BY END USER, 2021–2028 (USD MILLION) 129
10.2.2 US 130
10.2.2.1 Rising geriatric population to drive market 130
TABLE 84 US: BIOPSY DEVICES MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 130
10.2.3 CANADA 130
10.2.3.1 Government investments to support market growth 130
TABLE 85 CANADA: BIOPSY DEVICES MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 131
10.3 EUROPE 131
10.3.1 RECESSION IMPACT 132
TABLE 86 EUROPE: BIOPSY DEVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 132
TABLE 87 EUROPE: BIOPSY DEVICES MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 132
TABLE 88 EUROPE: NEEDLE-BASED BIOPSY INSTRUMENTS MARKET, BY TYPE, 2021–2028 (USD MILLION) 133
TABLE 89 EUROPE: CORE BIOPSY DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 133
TABLE 90 EUROPE: VACUUM-ASSISTED BIOPSY DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 133
TABLE 91 EUROPE: BIOPSY FORCEPS MARKET, BY TYPE, 2021–2028 (USD MILLION) 134
TABLE 92 EUROPE: BIOPSY DEVICES MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 134
TABLE 93 EUROPE: BIOPSY DEVICES MARKET, BY END USER, 2021–2028 (USD MILLION) 135
10.3.2 GERMANY 135
10.3.2.1 Increasing prevalence of chronic diseases to propel market 135
TABLE 94 GERMANY: BIOPSY DEVICES MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 135
10.3.3 FRANCE 136
10.3.3.1 Rising number of diagnostic imaging centers to drive market 136
TABLE 95 FRANCE: BIOPSY DEVICES MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 136
10.3.4 UK 137
10.3.4.1 Government initiatives to support market growth 137
TABLE 96 UK: BIOPSY DEVICES MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 137
10.3.5 ITALY 137
10.3.5.1 Availability of reimbursement coverage to support market growth 137
TABLE 97 ITALY: BIOPSY DEVICES MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 138
10.3.6 SPAIN 138
10.3.6.1 Increasing focus on cancer research to propel market 138
TABLE 98 SPAIN: BIOPSY DEVICES MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 139
10.3.7 REST OF EUROPE 139
TABLE 99 REST OF EUROPE: BIOPSY DEVICES MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 140
10.4 ASIA PACIFIC 140
10.4.1 RECESSION IMPACT 141
FIGURE 32 ASIA PACIFIC: BIOPSY DEVICES MARKET SNAPSHOT 141
TABLE 100 ASIA PACIFIC: BIOPSY DEVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 142
TABLE 101 ASIA PACIFIC: BIOPSY DEVICES MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 142
TABLE 102 ASIA PACIFIC: NEEDLE-BASED BIOPSY INSTRUMENTS MARKET, BY TYPE, 2021–2028 (USD MILLION) 143
TABLE 103 ASIA PACIFIC: CORE BIOPSY DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 143
TABLE 104 ASIA PACIFIC: VACUUM-ASSISTED BIOPSY DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 143
TABLE 105 ASIA PACIFIC: BIOPSY FORCEPS MARKET, BY TYPE, 2021–2028 (USD MILLION) 144
TABLE 106 ASIA PACIFIC: BIOPSY DEVICES MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 144
TABLE 107 ASIA PACIFIC: BIOPSY DEVICES MARKET, BY END USER, 2021–2028 (USD MILLION) 145
10.4.2 CHINA 145
10.4.2.1 Rapidly growing geriatric population to propel market 145
TABLE 108 CHINA: BIOPSY DEVICES MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 146
10.4.3 JAPAN 146
10.4.3.1 High adoption of advanced technologies to support market growth 146
TABLE 109 JAPAN: BIOPSY DEVICES MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 147
10.4.4 INDIA 147
10.4.4.1 Rising prevalence of chronic diseases to drive market 147
TABLE 110 INDIA: BIOPSY DEVICES MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 148
10.4.5 AUSTRALIA 148
10.4.5.1 Increasing investments in research to provide opportunities for market growth 148
TABLE 111 AUSTRALIA: BIOPSY DEVICES MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 149
10.4.6 SOUTH KOREA 149
10.4.6.1 Presence of well-developed healthcare system to propel market 149
TABLE 112 SOUTH KOREA: BIOPSY DEVICES MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 150
10.4.7 REST OF ASIA PACIFIC 150
TABLE 113 REST OF ASIA PACIFIC: BIOPSY DEVICES MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 150
10.5 LATIN AMERICA 151
10.5.1 RECESSION IMPACT 151
TABLE 114 LATIN AMERICA: BIOPSY DEVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 152
TABLE 115 LATIN AMERICA: BIOPSY DEVICES MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 152
TABLE 116 LATIN AMERICA: NEEDLE-BASED BIOPSY INSTRUMENTS MARKET, BY TYPE, 2021–2028 (USD MILLION) 153
TABLE 117 LATIN AMERICA: CORE BIOPSY DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 153
TABLE 118 LATIN AMERICA: VACUUM-ASSISTED BIOPSY DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 153
TABLE 119 LATIN AMERICA: BIOPSY FORCEPS MARKET, BY TYPE, 2021–2028 (USD MILLION) 154
TABLE 120 LATIN AMERICA: BIOPSY DEVICES MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 154
TABLE 121 LATIN AMERICA: BIOPSY DEVICES MARKET, BY END USER, 2021–2028 (USD MILLION) 155
10.5.2 BRAZIL 155
10.5.2.1 Favorable demographic conditions to drive market 155
TABLE 122 BRAZIL: BIOPSY DEVICES MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 156
10.5.3 MEXICO 156
10.5.3.1 Increased medical tourism and better government healthcare initiatives to drive market 156
TABLE 123 MEXICO: BIOPSY DEVICES MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 157
10.5.4 REST OF LATIN AMERICA 157
TABLE 124 REST OF LATIN AMERICA: BIOPSY DEVICES MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 158
10.6 MIDDLE EAST & AFRICA 158
10.6.1 GROWING MEDICAL TOURISM TO DRIVE MARKET 158
10.6.2 RECESSION IMPACT 159
TABLE 125 MIDDLE EAST & AFRICA: BIOPSY DEVICES MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 159
TABLE 126 MIDDLE EAST & AFRICA: NEEDLE-BASED BIOPSY INSTRUMENTS MARKET, BY TYPE, 2021–2028 (USD MILLION) 159
TABLE 127 MIDDLE EAST & AFRICA: CORE BIOPSY DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 160
TABLE 128 MIDDLE EAST & AFRICA: VACUUM-ASSISTED BIOPSY DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 160
TABLE 129 MIDDLE EAST & AFRICA: BIOPSY FORCEPS MARKET, BY TYPE, 2021–2028 (USD MILLION) 160
TABLE 130 MIDDLE EAST & AFRICA: BIOPSY DEVICES MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 161
TABLE 131 MIDDLE EAST & AFRICA: BIOPSY DEVICES MARKET, BY END USER, 2021–2028 (USD MILLION) 161
11 COMPETITIVE LANDSCAPE 162
11.1 OVERVIEW 162
11.2 KEY PLAYERS STRATEGIES 162
11.2.1 OVERVIEW OF STRATEGIES ADOPTED BY PLAYERS IN BIOPSY DEVICES MARKET 162
11.3 REVENUE SHARE ANALYSIS 162
FIGURE 33 TOP FIVE PLAYERS HAVE DOMINATED MARKET IN LAST FIVE YEARS 163
11.4 MARKET SHARE ANALYSIS 163
11.4.1 NEEDLE-BASED BIOPSY DEVICES MARKET 163
FIGURE 34 MARKET SHARE ANALYSIS OF TOP PLAYERS IN BIOPSY DEVICES MARKET (2022) 163
TABLE 132 INTENSITY OF COMPETITIVE RIVALRY FOR NEEDLE-BASED DEVICES AND ACCESSORIES MARKET PLAYERS 164
11.4.2 LIQUID BIOPSY MARKET 164
FIGURE 35 MARKET SHARE ANALYSIS OF TOP PLAYERS IN LIQUID BIOPSY MARKET (2022) 164
TABLE 133 INTENSITY OF COMPETITIVE RIVALRY FOR LIQUID BIOPSY MARKET PLAYERS 165
11.5 COMPANY EVALUATION MATRIX FOR KEY PLAYERS (2022) 166
11.5.1 STARS 166
11.5.2 EMERGING LEADERS 166
11.5.3 PERVASIVE PLAYERS 167
11.5.4 PARTICIPANTS 167
FIGURE 36 BIOPSY DEVICES MARKET: COMPANY EVALUATION MATRIX FOR KEY PLAYERS (2022) 167
11.5.5 COMPETITIVE BENCHMARKING 168
TABLE 134 BIOPSY DEVICES MARKET: PRODUCT AND REGIONAL FOOTPRINT ANALYSIS OF COMPANIES 168
TABLE 135 BIOPSY DEVICES MARKET-PRODUCT FOOTPRINT ANALYSIS OF COMPANIES FOR KEY PLAYERS 169
TABLE 136 BIOPSY DEVICES MARKET- REGIONAL FOOTPRINT ANALYSIS OF KEY COMPANIES 170
11.6 START-UP/SME EVALUATION MATRIX (2022) 171
11.6.1 PROGRESSIVE COMPANIES 171
11.6.2 RESPONSIVE COMPANIES 171
11.6.3 DYNAMIC COMPANIES 171
11.6.4 STARTING BLOCKS 171
FIGURE 37 BIOPSY DEVICES MARKET: COMPANY EVALUATION MATRIX FOR START-UPS/SMES (2022) 172
11.6.5 COMPETITIVE BENCHMARKING FOR START-UPS/SMES 172
TABLE 137 BIOPSY DEVICES MARKET: PRODUCT & REGIONAL FOOTPRINT ANALYSIS OF COMPANIES 172
TABLE 138 BIOPSY DEVICES MARKET-PRODUCT FOOTPRINT ANALYSIS OF COMPANIES FOR START-UP/SME PLAYERS 173
TABLE 139 BIOPSY DEVICES MARKET- REGIONAL FOOTPRINT ANALYSIS OF START-UP/SME COMPANIES 173
11.7 COMPETITIVE SCENARIOS AND TRENDS 174
TABLE 140 BIOPSY DEVICES MARKET: PRODUCT LAUNCHES (JANUARY 2020–AUGUST 2023) 174
TABLE 141 BIOPSY DEVICES MARKET: DEALS (JANUARY 2020–AUGUST 2023) 175
TABLE 142 BIOPSY DEVICES MARKET: OTHER DEVELOPMENTS (JANUARY 2020–AUGUST 2023) 176
12 COMPANY PROFILES 177
12.1 KEY PLAYERS 177
(Business overview, Products offered, Recent developments, MnM view, Key strengths/Right to win, Strategic choices made, and Weaknesses and Competitive threats)*
12.1.1 BECTON, DICKINSON AND COMPANY 177
TABLE 143 BECTON, DICKINSON AND COMPANY: BUSINESS OVERVIEW 177
FIGURE 38 BECTON, DICKINSON AND COMPANY: COMPANY SNAPSHOT (2022) 178
12.1.2 DEVICOR MEDICAL PRODUCTS, INC. (PART OF DANAHER CORPORATION) 182
TABLE 144 DANAHER CORPORATION: BUSINESS OVERVIEW 182
FIGURE 39 DANAHER CORPORATION: COMPANY SNAPSHOT (2022) 183
12.1.3 B. BRAUN MELSUNGEN AG 186
TABLE 145 B. BRAUN MELSUNGEN AG: BUSINESS OVERVIEW 186
FIGURE 40 B. BRAUN MELSUNGEN AG: COMPANY SNAPSHOT (2022) 187
12.1.4 CARDINAL HEALTH, INC. 189
TABLE 146 CARDINAL HEALTH, INC.: BUSINESS OVERVIEW 189
FIGURE 41 CARDINAL HEALTH, INC.: COMPANY SNAPSHOT (2022) 190
12.1.5 HOLOGIC, INC. 192
TABLE 147 HOLOGIC, INC.: BUSINESS OVERVIEW 192
FIGURE 42 HOLOGIC, INC.: COMPANY SNAPSHOT (2022) 193
12.1.6 OLYMPUS CORPORATION 195
TABLE 148 OLYMPUS CORPORATION: BUSINESS OVERVIEW 195
FIGURE 43 OLYMPUS CORPORATION: COMPANY SNAPSHOT (2022) 196
12.1.7 BOSTON SCIENTIFIC CORPORATION 198
TABLE 149 BOSTON SCIENTIFIC CORPORATION: BUSINESS OVERVIEW 198
FIGURE 44 BOSTON SCIENTIFIC CORPORATION: COMPANY SNAPSHOT (2022) 199
12.1.8 FUJIFILM CORPORATION 201
TABLE 150 FUJIFILM CORPORATION: BUSINESS OVERVIEW 201
FIGURE 45 FUJIFILM CORPORATION: COMPANY SNAPSHOT (2022) 202
12.1.9 MEDTRONIC PLC 204
TABLE 151 MEDTRONIC PLC: BUSINESS OVERVIEW 204
FIGURE 46 MEDTRONIC PLC: COMPANY SNAPSHOT (2022) 205
12.1.10 STRYKER CORPORATION 207
TABLE 152 STRYKER CORPORATION: BUSINESS OVERVIEW 207
FIGURE 47 STRYKER: COMPANY SNAPSHOT (2022) 208
12.1.11 COOK GROUP INCORPORATED 209
TABLE 153 COOK GROUP INCORPORATED: BUSINESS OVERVIEW 209
12.1.12 ARGON MEDICAL DEVICES 211
TABLE 154 ARGON MEDICAL DEVICES: BUSINESS OVERVIEW 211
12.1.13 INRAD, INC. 213
TABLE 155 INRAD, INC.: BUSINESS OVERVIEW 213
12.1.14 CONMED CORPORATION 214
TABLE 156 CONMED CORPORATION: BUSINESS OVERVIEW 214
12.1.15 TELEFLEX INCORPORATED 215
TABLE 157 TELEFLEX INCORPORATED.: BUSINESS OVERVIEW 215
FIGURE 48 TELEFLEX INCORPORATED: COMPANY SNAPSHOT (2022) 216
12.1.16 QIAGEN N.V. 217
TABLE 158 QIAGEN N.V.: BUSINESS OVERVIEW 217
FIGURE 49 QIAGEN N.V.: COMPANY SNAPSHOT (2022) 217
12.1.17 THERMO FISHER SCIENTIFIC, INC. 219
TABLE 159 THERMO FISHER SCIENTIFIC, INC.: BUSINESS OVERVIEW 219
FIGURE 50 THERMO FISHER SCIENTIFIC, INC.: COMPANY SNAPSHOT (2022) 220
12.2 OTHER PLAYERS 222
12.2.1 SUMMIT MEDICAL LLC 222
12.2.2 HILL-ROM HOLDINGS, INC. 222
12.2.3 GALLINI S.R.L 223
12.2.4 TRANSMED7, LLC 223
12.2.5 TSK LABORATORY INTERNATIONAL 224
12.2.6 MERIT MEDICAL SYSTEMS, INC. 224
12.2.7 DR. JAPAN CO., LTD. 225
12.2.8 IZI MEDICAL PRODUCTS 225
12.2.9 PLANMED OY 226
12.2.10 ADVIN HEALTH CARE 226
12.2.11 F. HOFFMANN-LA ROCHE LTD. 227
12.2.12 BIO-RAD LABORATORIES, INC. 227
12.2.13 ILLUMINA, INC. 228
*Details on Business overview, Products offered, Recent developments, MnM view, Key strengths/Right to win, Strategic choices made, and Weaknesses and Competitive threats might not be captured in case of unlisted companies.
13 APPENDIX 229
13.1 DISCUSSION GUIDE 229
13.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 232
13.3 CUSTOMIZATION OPTIONS 234
13.4 RELATED REPORTS 234
13.5 AUTHOR DETAILS 235